Literature DB >> 8165620

Importance of substrate composition, pH and other variables on tissue factor enhancement of factor VIIa activity.

P F Neuenschwander1, D E Branam, J H Morrissey.   

Abstract

Tissue factor (TF) markedly enhances the ability of factor VIIa (FVIIa) to cleave both macromolecular and small peptidyl substrates. Using soluble mutant TF (sTF) to investigate TF-enhanced FVIIa amidolytic activity in solution, we screened thirty-four commercially available peptidyl-p-nitroanilide substrates and found that substrate hydrolysis rates were influenced by both the peptide sequence and the N-terminal blocking group (MeSO2 > MeO-CO or free N-terminus >> benzoyl). Two substrates (Chromozym t-PA: MeSO2-D-Phe-Gly-Arg-pNA; and CBS 34.47: H-D-cyclohexylglycyl-alpha-aminobutyryl-Arg-pNA) were cleaved at rates higher than those of previously reported chromogenic substrates for FVIIa. The pH range of FVIIa amidolytic activity toward Chromozym t-PA was 6.5 to 10 with an optimum at pH 7.8, while sTF.VIIa had a higher pH optimum (pH 8.4 to 8.5). The degree of enhancement of FVIIa activity by sTF varied from 12-fold at pH 7.5 to 73-fold at pH 9.9. The effect of a variety of agents on FVIIa amidolytic activity was surveyed: most decreased activity, while glycerol and ethylene glycol enhanced the activity of FVIIa but not sTF.VIIa. These results indicate that the effect of sTF on the catalytic center of FVIIa is pH-dependent, and that certain polyalcohols can partially substitute for TF.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8165620

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  10 in total

1.  Correlation of factor IXa subsite modulations with effects on substrate discrimination.

Authors:  P F Neuenschwander; K J Deadmond; K Zepeda; J Rutland
Journal:  J Thromb Haemost       Date:  2012-03       Impact factor: 5.824

2.  The length of the linker between the epidermal growth factor-like domains in factor VIIa is critical for a productive interaction with tissue factor.

Authors:  Egon Persson; Jesper J Madsen; Ole H Olsen
Journal:  Protein Sci       Date:  2014-10-14       Impact factor: 6.725

3.  Disulfide locked variants of factor VIIa with a restricted beta-strand conformation have enhanced enzymatic activity.

Authors:  Henry R Maun; Charles Eigenbrot; Helga Raab; David Arnott; Lilian Phu; Sherron Bullens; Robert A Lazarus
Journal:  Protein Sci       Date:  2005-05       Impact factor: 6.725

4.  Sulfated, low molecular weight lignins inhibit a select group of heparin-binding serine proteases.

Authors:  Brian L Henry; Jay N Thakkar; Aiye Liang; Umesh R Desai
Journal:  Biochem Biophys Res Commun       Date:  2011-12-01       Impact factor: 3.575

5.  Direct Amplification of Tissue Factor:Factor VIIa Procoagulant Activity by Bile Acids Drives Intrahepatic Coagulation.

Authors:  Kevin S Baker; Anna K Kopec; Asmita Pant; Lauren G Poole; Holly Cline-Fedewa; Dora Ivkovich; Mojtaba Olyaee; Benjamin L Woolbright; Adam Miszta; Hartmut Jaeschke; Alisa S Wolberg; James P Luyendyk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-15       Impact factor: 8.311

6.  Interaction of antithrombin with sulfated, low molecular weight lignins: opportunities for potent, selective modulation of antithrombin function.

Authors:  Brian L Henry; Justin Connell; Aiye Liang; Chandravel Krishnasamy; Umesh R Desai
Journal:  J Biol Chem       Date:  2009-06-04       Impact factor: 5.157

7.  A novel allosteric pathway of thrombin inhibition: Exosite II mediated potent inhibition of thrombin by chemo-enzymatic, sulfated dehydropolymers of 4-hydroxycinnamic acids.

Authors:  Brian L Henry; Bernhard H Monien; Paul E Bock; Umesh R Desai
Journal:  J Biol Chem       Date:  2007-09-05       Impact factor: 5.157

Review 8.  Structure-Function Relationship of the Interaction between Tissue Factor and Factor VIIa.

Authors:  Joshua M Gajsiewicz; James H Morrissey
Journal:  Semin Thromb Hemost       Date:  2015-09-26       Impact factor: 4.180

9.  Inhibition of acute vascular thrombosis in chimpanzees by an anti-human tissue factor antibody targeting the factor X binding site.

Authors:  Jin-an Jiao; Andrew B Kelly; Ulla M Marzec; Esperanza Nieves; Jorge Acevedo; Martin Burkhardt; Ana Edwards; Xiao-yun Zhu; Pierre-Andre Chavaillaz; Alice Wong; Jeffrey L Wong; Jack O Egan; Dean Taylor; Peter R Rhode; Hing C Wong
Journal:  Thromb Haemost       Date:  2009-10-26       Impact factor: 5.249

10.  High-Resolution NMR Studies of Human Tissue Factor.

Authors:  Kristin M Nuzzio; Eric D Watt; John M Boettcher; Joshua M Gajsiewicz; James H Morrissey; Chad M Rienstra
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.